HCA Investigations No Harm to its Finances
HCA's latest settlement with the DOJ is the latest hit to the for-profit hospital chain, which, just a month ago, disclosed to investors on a second quarter earnings call that it was under a federal investigation by the DOJ for cardiac procedures performed at hospitals in Florida.
On the call, HCA pre-empted a New York Times investigation into its care of the indigent population and payment of ER doctors. That federal probe is ongoing and is unrelated to Wednesday's settlement. HCA stock closed down the day after the August 6th second quarter earnings call, but since then its stock price has risen by $6.96 per share.
"They're in very strong position, financially," says CRT's Skolnick. Perhaps because the company was only released from its eight-year CIA in 2009, she says she doesn't see evidence of a widespread problem at HCA. "The behaviors you learn while someone is watching your every move are hard to shake off," says Skolnick.
- MU Compliance Announcement Sparks Concern, Confusion
- New G-Codes to Pay Doctors for Broad Array of Non-Face-to-Face Care
- Scary Financial Challenges for 2014
- MGMA Urges 'End-to-End' ICD-10 Testing
- Telehealth Improves Patient Care in ICUs
- 1 in 5 CT Screenings for Lung Cancer Results in Overdiagnosis
- CMS Sets 2014 Pay Rates for Hospital Outpatient and Physician Services
- LifePoint Bolsters Presence in Michigan's Upper Peninsula
- States Rejecting Medicaid Expansion Forgo Billions in Federal Funds
- Douglas Hawthorne—A Chance to Do Something Big